Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO.

(600276)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
03/18/2019 03/19/2019 03/20/2019 03/21/2019 03/22/2019 Date
74.1(c) 72.1(c) 72.72(c) 72.4(c) 73.13(c) Last
29 163 100 23 528 983 17 086 417 12 572 709 13 484 402 Volume
+3.61% -2.70% +0.86% -0.44% +1.01% Change
More quotes
Financials (CNY)
Sales 2019 22 146 M
EBIT 2019 5 829 M
Net income 2019 5 253 M
Finance 2019 9 830 M
Yield 2019 0,25%
Sales 2020 27 505 M
EBIT 2020 7 439 M
Net income 2020 6 679 M
Finance 2020 15 407 M
Yield 2020 0,32%
P/E ratio 2019 51,80
P/E ratio 2020 40,48
EV / Sales2019 11,7x
EV / Sales2020 9,24x
Capitalization 270 B
More Financials
Company
Jiangsu Hengrui Medicine Co. specializes in the research, development, manufacture and marketing of pharmaceutical products. Net sales break down by product family as follows: - anti-tumor drugs (41.4%; No. 1 Chinese);- Anesthetic drugs (26%); - contrast agents (13.7%): used in medical... 
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
2018JIANGSU HENGRUI MEDICINE : LSK BioPharma and Jiangsu Hengrui Medicine Announce G..
AQ
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
2018JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
2018JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
2018JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
2018JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
BU
2017JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
2017JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
2016JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
More news
Analyst Recommendations on JIANGSU HENGRUI MEDICINE C
More recommendations
Sector news : Pharmaceuticals - NEC
08:57aBAYER : CEO says his team retains backing of supervisory board
RE
03/22FDA Rejects Oral Treatment for Type 1 Diabetes - Update
DJ
03/22ALLERGAN : promises independent board chair in next leadership change
RE
03/22FDA Rejects Oral Treatment for Type 1 Diabetes
DJ
03/22UPS to Test In-Home Vaccine Service in U.S. -Reuters
DJ
More sector news : Pharmaceuticals - NEC
Chart JIANGSU HENGRUI MEDICINE CO.
Duration : Period :
Jiangsu Hengrui Medicine Co. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 75,6  CNY
Spread / Average Target 3,3%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO.38.64%40 134
JOHNSON & JOHNSON6.09%364 560
NOVARTIS10.71%239 248
ROCHE HOLDING LTD.10.68%233 745
PFIZER-4.12%232 343
MERCK AND COMPANY7.70%212 409